Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Finles’ Dutch Hedge Fund Index has tough April, down 1.12% (+2.29% YTD)

Monday, May 21, 2012
Opalesque Industry Update - The Dutch Hedge Fund Index ended April 2012 -1.12% lower. More than the DB (-0,24%) and Lyxor Hedge Fund Indices (-0,02%) for the month but positive for the year (+2.29% Ytd).

April’s performance is a result of the weighting to Long/ Short Equity managers within the Index and more specifically the geographic focus of these managers.

Most managers tend to invest close to home and focus on European companies they know well and have an edge. Macro economic sentiment however punished European bourses hanging Grexit and whatmore. US and Asian markets posted much better numbers in April.

Correlations in Europe between companies and sectors crept back up as shares went down, making it difficult for fundamental stock pickers. Most Long/ Short Equity managers prefer times with more dispersion.

Results: Dutch Hedge Funds

The five best performing Dutch Hedge Funds in April were:
1. Aster-X Panorama Fund ….. +4,70%
2. Saemor Europe Alpha Fund ….. +3,62%
3. DQS Absolute Return Fund ….. +2,40%
4. Aster-X Europe Fund ….. +2,22%
5. Financial Care Fund ….. +1,89%

The five best performing Dutch Hedge Funds Ytd are:
1. Aster-X Panorama Fund ….. +23,29%
2. HiQ Invest Market Neutral Fund ….. +18,68%
3. Aster-X Europe Fund …. +17,71%
4. Tethys Alpheus Fund .... + 8,42%
5. Farringdon Alpha One Fund ..... + 8,21%

Communication from: Finles Capital Management
www.Finles.eu

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner